Clariant and South Korean BioSpectrum agree strategic partnership
(Thomson Reuters ONE) -
Clariant AG /
Clariant and South Korean BioSpectrum agree strategic partnership
. Processed and transmitted by NASDAQ OMX Corporate Solutions.
The issuer is solely responsible for the content of this announcement.
* BioSpectrum is a leading provider of natural active ingredients for
Personal Care with strong scientific capabilities in bioassay and claim
substantiation
* Clariant will become anchor shareholder and exclusive global distributor
* Strategic partnership will combine Biospectrum's research strengths with
Clariant's formulations expertise and global presence
Muttenz, April 12, 2016 - Clariant, a world leader in specialty chemicals,
signed an agreement to acquire a 17 % share in BioSpectrum, Inc ("BioSpectrum").
Headquartered in South Korea, BioSpectrum is a leading developer and supplier of
specialty active cosmetics' ingredients derived from Asia's diverse flora which
have proven benefits for humans.
Currently a family-owned business, BioSpectrum will remain an independently
managed company. Clariant will leverage its global sales and innovation network
to market BioSpectrum's product portfolio of active ingredients worldwide, with
the exception of Korea.
"The transaction will allow us to expand in the strategically important and
growing global markets for Personal Care applications. Our investment in
BioSpectrum will give us further access to highly innovative active ingredients
based on renewable raw materials. This corresponds to a growing consumer demand
for natural cosmetic ingredients, not only in the emerging markets of Asia but
worldwide", said Hariolf Kottmann, CEO of Clariant.
Christian Vang, Head of Business Unit Industrial & Consumer Specialties (BU ICS)
at Clariant, commented: "We are pleased about the strategic partnership with
BioSpectrum. The transaction will further enhance our earlier investment in the
partnership with Beraca in Latam America and leverages on our global customer
platform through exclusive distributorship. This strategic investment
strengthens and significantly enlarges Clariant's active ingredient portfolio,
reinforcing our ability to deliver a comprehensive range of natural, sustainable
and effective formulations to the Personal Care industry."
Dr. Deok-Hoon Park, CEO of BioSpectrum, added: "This partnership with Clariant
will be a key step in BioSpectrum's growth. We will have a strong partner on-
board supporting our fast and ambitious expansion plans and we foresee
tremendous innovation synergies that will lead us to create more value for
customers around the world."
BioSpectrum is renowned for its experience in researching and developing natural
raw materials that can be used in skin and hair care products. The company has
strong scientific capabilities in bioassay, efficacy testing and claim
substantiation,which allows the design and development of high-quality actives
ingredients for the cosmetics industry. All of the ingredients are based on
state-of-the-art technology and have been widely tested and developed to meet
the demands and trends of the cosmetics industry.
BioSpectrum's portfolio of functional ingredients is derived from natural
products and extracts from exotic Asian plants, in particular those found on the
South Korean Jeju Island - an isolated mountain formed by volcanic eruption and
featuring over 1,800 plant species. Its formulation ingredients include active
compounds offering moisturizing, whitening, anti-aging, wound healing, anti-
acne, skin soothing, anti-inflammation, anti-dandruff, detoxification and body
slimming effects.
Corporate Media Relations Investor Relations
Carsten Seum Anja Pomrehn
Phone +41 61 469 63 63 Phone +41 61 469 67 45
carsten.seum(at)clariant.com anja.pomrehn(at)clariant.com
Claudia Kamensky Steven Massheder
Phone +41 61 469 63 63 Phone +41 61 469 68 58
claudia.kamensky(at)clariant.com steven.massheder(at)clariant.com
gLOBAL tRADE MEDIA RELATIONS
Stefanie Nehlsen
Phone +41 61 469 63 63
stefanie.nehlsen(at)clariant.com
Media Release english:
http://hugin.info/100166/R/2002542/739075.pdf
Media Release german:
http://hugin.info/100166/R/2002542/739076.pdf
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Clariant AG via GlobeNewswire
[HUG#2002542]
Unternehmensinformation / Kurzprofil:
Datum: 12.04.2016 - 07:00 Uhr
Sprache: Deutsch
News-ID 463242
Anzahl Zeichen: 5324
contact information:
Town:
Muttenz 1
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 178 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Clariant and South Korean BioSpectrum agree strategic partnership"
steht unter der journalistisch-redaktionellen Verantwortung von
Clariant AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
